| Pretraživanje | Osvježi |
|
RheumaHighlights
@RheumaH
|
1 h |
|
Good news! The ACR/ARP highlights are now available in Chinese 🇨🇳 and Japanese 🇯🇵 languages ➡️rheumahighlights.com Get the most out of #ACR19!
#rheumahighlights #rheumatology
|
||
|
|
||
|
Martin Greco
@MartinGrec0
|
16. stu |
|
Presenting our poster "Antisynthetase Syndromes: Correlation of IIFA Patterns with Diagnosis Criteria Fulfillment" at #ACR19 in Atlanta. Many thanks to @fmguanarteme, @MdicosLasPalmas and @SEReumatologia for contributing to this project and its presentation at this meeting. pic.twitter.com/jtIa7cApl9
|
||
|
||
|
𝐽𝑎𝑣𝑖𝑒𝑟 𝑀𝑒𝑟𝑎𝑦𝑜-𝐶ℎ𝑎𝑙𝑖𝑐𝑜
@MerayoDr
|
13. stu |
|
#ACR2019 #acr19 new Guidelines OA:
🥊exercise (aerobic/streng/neuroM/aquatic🏖)
🥝🥬🔽weigth🚫🍔🚫
✅tai chi
🚫TENS🚫(no evidence)
✅topical/oral NDSAIDs/intraarticular GCs
🚫intraarticular HyA (hip)🚫
🚫glucosamine and/or chondroitin🚫
(Look slides 👁👁) pic.twitter.com/Y76IECqkPJ
|
||
|
||
|
Mike Putman
@EBRheum
|
21. stu |
|
#tbt #ACR19 "Update in Myositis" session with tips on how to use the new classification criteria
I honestly find them difficult and only reference in marginal cases
Excellent tables from the presentation, though - great reference for antibodies and presentations! @RheumNow pic.twitter.com/SyzhLZHtcI
|
||
|
||
|
Mike Putman
@EBRheum
|
22. stu |
|
#tbt #ACR19 - Update in Myositis: Don't forget about toxin induced myopathy!
Important mimickers related to treatment we give!
1. Steroid: myopathy w/o inflammation
2. Colchicine: vacuolar myopathy
3. Anti-malarial: vacuolar degeneration
P.S. This might be good boards prep... pic.twitter.com/m48UkZlGP3
|
||
|
||
|
Lauren Gelman
@laurenbgelman
|
25. stu |
|
Excited to share this @CreakyJoints report of the big #ACR19 takeaways for patients, with lots of help from @rheum_cat @psufka @EBRheum @HealioRheum @RheumNow & others. Too much to pack into just one resource, so we have 6 wrap-up stories this year!
creakyjoints.org/education/acr-…
|
||
|
|
||
|
American College of Rheumatology
@ACRheum
|
4. velj |
|
We’ve got another special Hot Topics episode available on the podcast! Join our host Dr. Hausmann, along with Dr. Ali Duarte Garcia and Dr. Suleman Bhana, as they discuss studies featured in #ACR19 press conferences. acr.tw/32Na5F8 pic.twitter.com/1yVFUL5xX0
|
||
|
||
|
Sjögren’s Expertise Center Groningen
@SjogrensUMCG
|
12. stu |
|
Multiple SS-clinical trial results presented at #ACR19. The challenge to identify responders remains! Lots of interest for our abatacept follow-up data (week 48) presented by Jolien! pic.twitter.com/ayhnCLeiWs
|
||
|
||
|
Dr. John Cush
@RheumNow
|
16. pro |
|
Retrospective cohort study of 154 RA patients undergoing 244 major surgeries in shows that perioperative use of DMARDs (39%) or biologics (13%) was not associated with 30-day odds of post-operative infection #ACR19 Abst #1805 bit.ly/34rmyie
|
||
|
|
||
|
Mai Abdelnabi, MD
@MaiAbdelnabi12
|
13. stu |
|
Scleroderma treatment options #ACR19 pic.twitter.com/IZraazAYfL
|
||
|
||
|
Kanika Monga, MD
@DrKanikaMonga
|
15. stu |
|
❓Can the happiest subspecialists experience burnout?
🌻 Now back from #ACR19, I am rekindled with a new spark and inspiration thanks to each and every one of you!
⬇️ Please read my article for @RheumNow on burnout in rheumatology:
bit.ly/32OXCkb
|
||
|
|
||
|
Laurent ARNAUD
@Lupusreference
|
14. stu |
|
🔹Are you looking 🔎 for a visual summary 📑 of the main #clinicaltrials (and their #targets 🎯 & #outcomes) for the #treatment 💊 of systemic #lupus presented at #ACR19? #SLE🔹
Well...here it is! pic.twitter.com/kx1EE3zCXq
|
||
|
||
|
Mike Putman
@EBRheum
|
3. pro |
|
Management of GCA Guidelines from #ACR19 (FIXED!):
The presenter went quickly by the slide on methotrexate & the slide deck was not available during the presentation.
Small update now that slides are available, MTX recs included: "[MTX] can be considered as initial treatment" pic.twitter.com/Cm7jBPeGZz
|
||
|
||
|
Dr. Rachel Tate
@uptoTate
|
14. stu |
|
Asymptomatic sacroiliitis was observed in about 15% of young IBD pts. Entero MRI may be helpful for early inflammatory changes in IBD pts. abst #1174 #ACR19 @RheumNow ow.ly/v4r350x78Lx
|
||
|
|
||
|
Dr. Paul Sufka
@psufka
|
23. stu |
|
I missed this one during #ACR19 (found via @RheumNow's weekly roundup):
Abstract L19: Early study, but BAFF inhibitor Ianalumab met its primary endpoint in primary Sjogren's.
acrabstracts.org/abstract/ianal…
|
||
|
|
||
|
emily creek
@emilylcreek
|
13. stu |
|
Thanks to the AF patients who shared their voice and influenced the new ACR/AF OA Treatment Guidelines. @ArthritisFdn #ACR19 pic.twitter.com/fKgN3mmLwH
|
||
|
||
|
Eileen Davidson
@chroniceileen
|
18. stu |
|
I wrote about being a first time patient at @ACRheum #ACR19 . What an amazing experience, I WILL go again! Thank you @Arthritis_ARC for sponsoring me! Thank you @steveston_gal for being my mentor. Also thanks to those who came to see me speak!
bit.ly/37hHwmD
|
||
|
|
||
|
David Liew
@drdavidliew
|
15. stu |
|
Rheumatic irAEs can:
- be severe
- be related to oncological response
- come on anytime after immunotherapy initiation
- persist long after immunotherapy cessation
Data from #ACR19 @RheumNow: acr19.rheumnow.com/news/rheumatic…
@cappelliMD @Richter_MD @UmaThanaMD @CCalabreseDO @LCalabreseDO
|
||
|
|
||
|
Madelaine Feldman
@MattieRheumMD
|
13. stu |
|
My Utilization management presentation at #ACR19 was picked up by AJMC.com. Check it out. @CSROAdvocacy @ATAPAdvocates How Prior Authorization, Step Therapy Result in Medication Discontinuation and Worse Outcomes ajmc.com/conferences/ac… via @AJMC_Journal
|
||
|
|
||
|
emily creek
@emilylcreek
|
13. stu |
|
ACR/AF OA Treatment Guidelines include strong recommendation for exercise. @ArthritisFdn #ACR19. pic.twitter.com/VVBMXTg1XP
|
||
|
||